BioPharmX Corporation, a specialty pharmaceutical company, announced that research being presented at ASCB 2015 in San Diego shows its unique formulation of

This content is restricted to site members. If you are an existing user, please log in. New users may register below.

New User Registration
 
 
 
 
 
 
 
 
*Required field